Skip to content

Treatments

Weight loss treatments

Licensed weight-management treatments in the UK are prescription-only medicines, prescribed after clinical assessment where they are appropriate. They work by acting on appetite regulation rather than on fat directly, which is why they are used alongside dietary and activity change rather than instead of it.

A prescriber listening to a patient during a medical weight management consultation, across a desk in a daylit consulting room

Mounjaro

Licensed for weight management

Tirzepatide · Once-weekly subcutaneous injection

Mounjaro is the brand name for tirzepatide, a once-weekly injection licensed in the UK for weight management. It activates two gut hormone receptors, GIP and GLP-1, which together reduce appetite and slow how quickly the stomach empties.

Read the full guide

Wegovy

Licensed for weight management

Semaglutide · Once-weekly subcutaneous injection

Wegovy is the brand name for semaglutide 2.4 mg, a once-weekly injection licensed in the UK for weight management. It acts on the GLP-1 receptor, reducing appetite and slowing gastric emptying so that people feel full sooner and for longer.

Read the full guide

Saxenda

Licensed for weight management

Liraglutide · Once-daily subcutaneous injection

Saxenda is the brand name for liraglutide 3.0 mg, a once-daily injection licensed in the UK for weight management. Like the weekly treatments it acts on the GLP-1 receptor to reduce appetite and slow gastric emptying, but liraglutide has a shorter duration of action, which is why it must be injected every day rather than once a week..

Read the full guide

Ozempic

Licensed, other indication

Semaglutide · Once-weekly subcutaneous injection

Ozempic is the brand name for semaglutide licensed to treat type 2 diabetes. It is not licensed for weight loss in the UK.

Read the full guide

Treatment options and pricing are discussed following clinical assessment, as required for prescription-only medicines.

Start your assessment